GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global External Ventricular Drain Market, By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other), By Patient Type (Pediatric, Adult), By End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Global External Ventricular Drain Market- Recent Developments

In August 2022, Brain Navi Biotechnology, a surgical robotic company based in China, announced that NaoTrac, the Conformité Européenne (CE) certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the U.S. Food and Drug Administration (USFDA) for clearance by the end of 2022. The NaoTrac human trials were performed at the reputable Hualien Tzu-Chi Medical Center, with the external ventricular drain (EVD).
In October 2021, RAUMEDIC, a medical-technology company, announced the expansion of its manufacturing unit in Mills River, North Carolina, U.S.